Expression of binding of plasminogen, thrombospondin, vitronectin, and fibrinogen, and adhesive properties by Escherichia coli strains isolated from patients with colonic diseases

Gut

Volumn 36, Issue 3, 1995, Pages 401-406

  Shen, W ^a   Steinruck H ^b   Ljungh, A ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b ROBERT KOCH INSTITUTE   (Germany)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Adhesive properties; Colonic disease; E coli; Protein binding expression

Indexed keywords

FIBRINOGEN; PLASMINOGEN; THROMBOSPONDIN; VITRONECTIN;

ARTICLE; COLON DISEASE; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0028948421     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.36.3.401     Document Type: Article

References (38)

1. Ljungh Å. Microbiological aspects of inflammatory bowel disease. In Järnerot G, Lennard-Jones J, Truelove S, eds. Inflammatory bowel disease. Malmö: Corona Press, 1992: 73-89.
2. Meyers S, Mayer L, Bottone E, Desmond E, Janowitz H. Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology 1981; 80: 697-700.
3. Lungh Å, Eriksson M, Eriksson O, Henter J-I, Wadström T. Shiga-like toxin production and connective tissue protein binding of Escherichia coli isolated from a patient with ulcerative colitis. Scand J Infect Dis 1988; 20: 443-6.
4. Olusanya O, Steinrück H, Aleljung P, Ascencio F, Curman B, Järnerot G, et al. Surface properties, connective tissue protein binding and Shiga-like toxin production of Escherichia coli isolated from patients with ulcerative colitis, Int J Med Microbiol 1992; 276: 254-63.
5. von Wulffen H, Russman H, Karch H. Verocytotoxin-producing Escherichia coli O2:H5 isolated from patients with ulcerative colitis. Lancet 1988; i: 1449-50.
6. Ljungh Å, Aleljung P, Malmer C, Selander B, Wadström T. Subepithelial connective-tissue protein binding in Escherichia coli isolated from patients with ulcerative colitis and healthy persons. Microbial Ecology and Therapy 1993; 21.
7. Ljungh Å, Wadström T. Subepithelial connective tissue protein binding of Escherichia coli isolated from patients with ulcerative colitis. In: McDermott RP, ed. Inflammatory bowel disease: current status and future approach. Amsterdam: Elsevier Science, 1988: 571-5.
8. Giaffer MH, Holdsworth CD, Duerden BI. Virulence properties of Escherichia coli isolated from patients with inflammatory bowel disease. Gut 1992; 33: 646-50.
9. Burke DA, Axon ATR. Hydrophobic adhesin of Escherichia coli in ulcerative colitis. Gut 1988; 29: 41-3.
10. Levine MM, Prado V, Robins-Browne R, Lior H, Kaper JB, Moseley SL, et al. Use of DNA probes and HEp-2 cell adherence assay to detect diarrheagenic Escherichia coli. J Infect Dis 1988; 158: 224-8.
11. Donnenberg MS, Donohue-Rolfe A, Keusch GT. Epithelial cell invasion an overlooked property of emeropathogenic Escherichia coli associated with the EPEC adherence factor. J Infect Dis 1989; 160: 452-9.
12. Andrade JRC, Da Veiga VF, Santa Rosa MR, Suassuna I. An endocytic process in HEp-2 cells induced by enteropathogenic Escherichia coli. J Med Microbiol 1989; 28: 49-57.
13. Fletcher JN, Embaye HE, Getty B, Ban RM, Hart CA, Saunders JR. Novel invasion determinant of enteropathogenic Escherichia coli plasmid pLV501 encodes the ability to invade intestinal epithelial cells and HEp-2 cells. Infect Immun 1992; 60: 2229-36.
14. Schumacher G, Steinrück H, Geyid A, Kollberg B, Ljungh A. Virulence properties of Escherichia coli isolated from the rectal mucosa of patients with first attacks of colitis. Microbial Ecology in Health and Disease (in press).
15. Slomiany A, Okazaki K, Tamura S, Slomiany BL. Identity of mucin's 18-kDa link protein' with fibronectin fragment. Arch Biochem Biophys 1991; 286: 383-8.
16. Örskov F, Örskov I. Serotyping of Escherichia coli. In: Bergan T, Noms JR, eds. Methods of microbiology. London: Academic Press, 1978; 14: 1-77.
17. Evans DG, Evans Jr DJ, Tjoa WS, DuPont HL. Detection and characterization of colonization factor of enterotoxigenic Escherichia coli isolated from adults with diarrhea. Infect Immun 1978; 19: 727-36.
18. Lindahl M, Paris A, Wadström T, Hjertén S. A new test based on 'salting out' to measure relative surface hydrophobicity of bacterial cells. Biochim Biophys Acta 1981; 677: 471-6.
19. Markwell MAK. A new solid state reagent to iodinate proteins. Anal Biochem 1982; 125: 427-32.
20. Ljungh Å Emödy L, Steinrück H, Sullivan PB, West B, Zetterberg E, et al. Fibronectin, vitronectin and collagen binding to Escherichia coli of intestinal and extraintestinal origin. Int J Med Microbiol 1990; 274: 126-34.
21. Ljungh Å, Emödy L, Aleljung P, Olusanya O, Wadström T. Growth conditions for the expression of fibronectin, collagen type I, vitronectin and laminin binding to Escherichia coli strain NG7C. Current Microbiology 1991; 22: 97-102.
22. Wiström J, Gentry LO, Palmgren A-C, Price M, Nord C-E, Ljungh A, et al. Ecological effects of short-term ciprofloxacin treatment of travellers' diarrhoea. J Antimicrob Chemother 1992; 30: 693-706.
23. Cravioto A, Tello A, Navarro A, Ruiz J, Villafán H, Uribe F, et al. Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhoea. Lancet 1991; 337: 262-4.
24. Knutton S, Baldwin T, Williams PH, McNeish AS. Actin accumulation at sites of bacterial adhesion to tissue culture cells. Basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli. Infect Immun 1989; 57: 1290-8.
25. Yatohgo T, Izumi M, Kashiwagi H, Hayashi M. Novel purification of vitronectin for human plasma by heparin affinity chromatography. Cell Struct Funct 1988; 13: 281-92.
26. Vuento M, Vaheri A. Purification of fibronectin from plasma by affinity chromatography under non-denaturing conditions. Biochem J 1979; 183: 331-7.
27. Cooke EM, Ewins SP, Hywel-Jones J, Lennard-Jones JE. Properties of strains of Escherichia coli carried in different phases of ulcerative colitis. Gut 1974; 15: 143-6.
28. Schumacher G, Kollberg B, Sandstedt B, Jorup C, Grillner L, Ljungh A, et al. A prospective study of non-relapsing colitis and first attacks of inflammatory bowel disease. Scand J Gastroenterol 1993; 28: 1077-85.
29. Yu J, Kaper JB. Cloning and characterization of the eae gene of enterohæmorrhagic Escherichia coli O157:H7. Mol Microbiol 1992; 6: 411-7.
30. Gulig PA, Curtiss III R. Plasmid-associated virulence of Salmonella typhimurium. Infect Immun 1987; 55: 2891-901.
31. Dahlbäck B, Podack ER. Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Biochem J 1985; 24: 2368-74.
32. Boyle MDP. Bacterial immunoglobulin-binding proteins I. San Diego: Academic Press, 1990.
33. Kuusela P, Saksela O. Binding and activation of plasminogen at the surface of Staphylococcus aureus. Eur J Biochem 1990; 193: 759-65.
34. Kuusela P, Kaukoranta-Tolvanen S-F, Ullberg M, Kronvall G, Saksela O. Surface associated activation of plasminogen on staphylococci and streptococci, and novel mechanisms for bacteriemia to use the activator system of the host. In: Wadström T, Holder IA, Kronvall G, eds. Molecular pathogenesis of surgical infections. Stuttgart: Gustav Fischer Verlag (in press).
35. Ullberg M, Kronvall G, Karlsson I, Wiman B. Receptors for human plasminogen on Gram-negative bacteria. Infect Immun 1990; 58: 21-5.
36. Parkkinen J, Hacker J, Korhonen TK. Enhancement of tissue plasminogen activator-catalyzed plasminogen activation by Escherichia coli S fimbriæ; associated with neonatal septicæmia and meningitis. Thromb Hœmost 1991; 65: 483-6.
37. Herrman M, Suchard SJ, Boxer LA, Waldvogel FA, Lew PD. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun 1991; 59: 279-88.
38. Rose PE, Armour JA, Williams CE, Hill FGH. Verotoxin and neuraminidase induced platelet aggregation activity in plasma: their possible role in the pathogenesis of the hæmolytic uræmic syndrome. J Clin Pathol 1985; 38: 438-41.